Y-mAbs Therapeutics, Inc. (YMAB) CEO Thomas Gad on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/14/22
YmAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/09/22
Y-mAbs Announces First Quarter Financial Results and Recent Corporate DevelopmentsGlobeNewsWire • 05/09/22
Y-mAbs to Announce First Quarter 2022 Financial and Operating Results on May 9, 2022GlobeNewsWire • 05/03/22
Earnings Preview: YmAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to DeclineZacks Investment Research • 04/28/22
Y-mAbs Announces Executive Management Changes and Provides 2022 Revenue Guidance and Financial UpdateGlobeNewsWire • 04/27/22
Y-mAbs Announces Submission of Omburtamab Biologics License Application to FDAGlobeNewsWire • 04/01/22
YmAbs Therapeutics, Inc. (YMAB) Soars 11.3%: Is Further Upside Left in the Stock?Zacks Investment Research • 03/21/22
Moore Kuehn, PLLC Encourages Investors of Y-mAbs Therapeutics, Inc. to Contact Law FirmNewsfile Corp • 03/17/22
Y-MAbs Therapeutics, Inc. (YMAB) CEO Claus Møller on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22
YmAbs Therapeutics, Inc. (YMAB) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 02/25/22
Y-mAbs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate DevelopmentsGlobeNewsWire • 02/24/22
Earnings Preview: YmAbs Therapeutics, Inc. (YMAB) Q4 Earnings Expected to DeclineZacks Investment Research • 02/17/22
YmAbs Therapeutics, Inc. (YMAB) Soars 8.3%: Is Further Upside Left in the Stock?Zacks Investment Research • 02/01/22
Y-mAbs Therapeutics, Inc.'s (YMAB) CEO Claus Moller on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/05/21
YmAbs Therapeutics, Inc. (YMAB) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/04/21
Y-mAbs Announces Third Quarter Financial Results and Recent Corporate DevelopmentsGlobeNewsWire • 11/04/21
Y-mAbs Provides Regulatory Update on Omburtamab for the Treatment of Patients with Neuroblastoma CNS/LM MetastasisGlobeNewsWire • 11/04/21
Y-mAbs to Announce Third 2021 Financial and Operating Results on November 4, 2021GlobeNewsWire • 10/28/21